title: Phenytoin for neuroprotection - Authors' reply.
authors.affiliation: National Hospital for Neurology and Neurosurgery, London, UK; University College London Institute of Neurology, London, WC1N 3BG, UK; Queen Square Multiple Sclerosis Centre, London, UK. Electronic address: r.kapoor@nhs.net.
authors.forename: Raju
authors.initials: R
authors.lastname: Kapoor
authors.affiliation: National Hospital for Neurology and Neurosurgery, London, UK; University College London Institute of Neurology, London, WC1N 3BG, UK; Queen Square Multiple Sclerosis Centre, London, UK.
authors.forename: Rhian
authors.initials: R
authors.lastname: Raftopoulos
authors.affiliation: Queen Square Multiple Sclerosis Centre, London, UK; Medical Statistics Department, London School of Hygiene and Tropical Medicine, London, UK.
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Altmann
authors.affiliation: National Hospital for Neurology and Neurosurgery, London, UK; University College London Institute of Neurology, London, WC1N 3BG, UK; Queen Square Multiple Sclerosis Centre, London, UK.
authors.forename: David H
authors.initials: DH
authors.lastname: Miller
authors.affiliation: Royal Hallamshire Hospital, Sheffield, UK.
authors.forename: Simon J
authors.initials: SJ
authors.lastname: Hickman
mesh_terms: D000066829:Neuroprotection; D010672:Phenytoin
chemical_list: D010672:Phenytoin